The effects of intra-articular resiniferatoxin on monosodium iodoacetate-induced osteoarthritic pain in rats

Youngkyung Kim, Eun Hye Kim, Kyu Sang Lee, Koeun Lee, Sung Ho Park, Sook Hyun Na, Cheolwoong Ko, Junesun Kim, Young Wook Yoon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

This study was performed to investigate whether an intra-articular injection of transient receptor potential vanilloid 1 (TRPV1) receptor agonist, resiniferatoxin (RTX) would alleviate behavioral signs of arthritic pain in a rat model of osteoarthritis (OA). We also sought to determine the effect of RTX treatment on calcitonin gene-related peptide (CGRP) expression in the spinal cord. Knee joint inflammation was induced by intra-articular injection of monosodium iodoacetate (MIA, 8 mg/50 μl) and weight bearing percentage on right and left hindpaws during walking, paw withdrawal threshold to mechanical stimulation, and paw withdrawal latency to heat were measured to evaluate pain behavior. Intra-articular administration of RTX (0.03, 0.003 and 0.0003%) at 2 weeks after the induction of knee joint inflammation significantly improved reduction of weight bearing on the ipsilateral hindlimb and increased paw withdrawal sensitivity to mechanical and heat stimuli. The reduction of pain behavior persisted for 3∼10 days according to each behavioral test. The MIA-induced increase in CGRP immunoreactivity in the spinal cord was decreased by RTX treatment in a dose-dependent manner. The present study demonstrated that a single intra-articular administration of RTX reduced pain behaviors for a relatively long time in an experimental model of OA and could normalize OA-associated changes in peptide expression in the spinal cord.

Original languageEnglish
Pages (from-to)129-136
Number of pages8
JournalKorean Journal of Physiology and Pharmacology
Volume20
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Iodoacetates
Joints
Pain
Osteoarthritis
Intra-Articular Injections
Spinal Cord
Calcitonin Gene-Related Peptide
Weight-Bearing
Knee Joint
Hot Temperature
Inflammation
Hindlimb
Walking
Arthritis
Theoretical Models
resiniferatoxin
Peptides
Therapeutics

Keywords

  • Calcitonin gene-related peptide (CGRP)
  • Joint pain
  • Monosodium iodoacetate (MIA)
  • Osteoarthritis
  • Resiniferatoxin (RTX)

ASJC Scopus subject areas

  • Pharmacology
  • Physiology

Cite this

The effects of intra-articular resiniferatoxin on monosodium iodoacetate-induced osteoarthritic pain in rats. / Kim, Youngkyung; Kim, Eun Hye; Lee, Kyu Sang; Lee, Koeun; Park, Sung Ho; Na, Sook Hyun; Ko, Cheolwoong; Kim, Junesun; Yoon, Young Wook.

In: Korean Journal of Physiology and Pharmacology, Vol. 20, No. 1, 01.01.2016, p. 129-136.

Research output: Contribution to journalArticle

Kim, Youngkyung ; Kim, Eun Hye ; Lee, Kyu Sang ; Lee, Koeun ; Park, Sung Ho ; Na, Sook Hyun ; Ko, Cheolwoong ; Kim, Junesun ; Yoon, Young Wook. / The effects of intra-articular resiniferatoxin on monosodium iodoacetate-induced osteoarthritic pain in rats. In: Korean Journal of Physiology and Pharmacology. 2016 ; Vol. 20, No. 1. pp. 129-136.
@article{f10dc5e376514077ada664335a22af17,
title = "The effects of intra-articular resiniferatoxin on monosodium iodoacetate-induced osteoarthritic pain in rats",
abstract = "This study was performed to investigate whether an intra-articular injection of transient receptor potential vanilloid 1 (TRPV1) receptor agonist, resiniferatoxin (RTX) would alleviate behavioral signs of arthritic pain in a rat model of osteoarthritis (OA). We also sought to determine the effect of RTX treatment on calcitonin gene-related peptide (CGRP) expression in the spinal cord. Knee joint inflammation was induced by intra-articular injection of monosodium iodoacetate (MIA, 8 mg/50 μl) and weight bearing percentage on right and left hindpaws during walking, paw withdrawal threshold to mechanical stimulation, and paw withdrawal latency to heat were measured to evaluate pain behavior. Intra-articular administration of RTX (0.03, 0.003 and 0.0003{\%}) at 2 weeks after the induction of knee joint inflammation significantly improved reduction of weight bearing on the ipsilateral hindlimb and increased paw withdrawal sensitivity to mechanical and heat stimuli. The reduction of pain behavior persisted for 3∼10 days according to each behavioral test. The MIA-induced increase in CGRP immunoreactivity in the spinal cord was decreased by RTX treatment in a dose-dependent manner. The present study demonstrated that a single intra-articular administration of RTX reduced pain behaviors for a relatively long time in an experimental model of OA and could normalize OA-associated changes in peptide expression in the spinal cord.",
keywords = "Calcitonin gene-related peptide (CGRP), Joint pain, Monosodium iodoacetate (MIA), Osteoarthritis, Resiniferatoxin (RTX)",
author = "Youngkyung Kim and Kim, {Eun Hye} and Lee, {Kyu Sang} and Koeun Lee and Park, {Sung Ho} and Na, {Sook Hyun} and Cheolwoong Ko and Junesun Kim and Yoon, {Young Wook}",
year = "2016",
month = "1",
day = "1",
doi = "10.4196/kjpp.2016.20.1.129",
language = "English",
volume = "20",
pages = "129--136",
journal = "Korean Journal of Physiology and Pharmacology",
issn = "1226-4512",
publisher = "Korean Physiological Soc. and Korean Soc. of Pharmacology",
number = "1",

}

TY - JOUR

T1 - The effects of intra-articular resiniferatoxin on monosodium iodoacetate-induced osteoarthritic pain in rats

AU - Kim, Youngkyung

AU - Kim, Eun Hye

AU - Lee, Kyu Sang

AU - Lee, Koeun

AU - Park, Sung Ho

AU - Na, Sook Hyun

AU - Ko, Cheolwoong

AU - Kim, Junesun

AU - Yoon, Young Wook

PY - 2016/1/1

Y1 - 2016/1/1

N2 - This study was performed to investigate whether an intra-articular injection of transient receptor potential vanilloid 1 (TRPV1) receptor agonist, resiniferatoxin (RTX) would alleviate behavioral signs of arthritic pain in a rat model of osteoarthritis (OA). We also sought to determine the effect of RTX treatment on calcitonin gene-related peptide (CGRP) expression in the spinal cord. Knee joint inflammation was induced by intra-articular injection of monosodium iodoacetate (MIA, 8 mg/50 μl) and weight bearing percentage on right and left hindpaws during walking, paw withdrawal threshold to mechanical stimulation, and paw withdrawal latency to heat were measured to evaluate pain behavior. Intra-articular administration of RTX (0.03, 0.003 and 0.0003%) at 2 weeks after the induction of knee joint inflammation significantly improved reduction of weight bearing on the ipsilateral hindlimb and increased paw withdrawal sensitivity to mechanical and heat stimuli. The reduction of pain behavior persisted for 3∼10 days according to each behavioral test. The MIA-induced increase in CGRP immunoreactivity in the spinal cord was decreased by RTX treatment in a dose-dependent manner. The present study demonstrated that a single intra-articular administration of RTX reduced pain behaviors for a relatively long time in an experimental model of OA and could normalize OA-associated changes in peptide expression in the spinal cord.

AB - This study was performed to investigate whether an intra-articular injection of transient receptor potential vanilloid 1 (TRPV1) receptor agonist, resiniferatoxin (RTX) would alleviate behavioral signs of arthritic pain in a rat model of osteoarthritis (OA). We also sought to determine the effect of RTX treatment on calcitonin gene-related peptide (CGRP) expression in the spinal cord. Knee joint inflammation was induced by intra-articular injection of monosodium iodoacetate (MIA, 8 mg/50 μl) and weight bearing percentage on right and left hindpaws during walking, paw withdrawal threshold to mechanical stimulation, and paw withdrawal latency to heat were measured to evaluate pain behavior. Intra-articular administration of RTX (0.03, 0.003 and 0.0003%) at 2 weeks after the induction of knee joint inflammation significantly improved reduction of weight bearing on the ipsilateral hindlimb and increased paw withdrawal sensitivity to mechanical and heat stimuli. The reduction of pain behavior persisted for 3∼10 days according to each behavioral test. The MIA-induced increase in CGRP immunoreactivity in the spinal cord was decreased by RTX treatment in a dose-dependent manner. The present study demonstrated that a single intra-articular administration of RTX reduced pain behaviors for a relatively long time in an experimental model of OA and could normalize OA-associated changes in peptide expression in the spinal cord.

KW - Calcitonin gene-related peptide (CGRP)

KW - Joint pain

KW - Monosodium iodoacetate (MIA)

KW - Osteoarthritis

KW - Resiniferatoxin (RTX)

UR - http://www.scopus.com/inward/record.url?scp=84956879092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956879092&partnerID=8YFLogxK

U2 - 10.4196/kjpp.2016.20.1.129

DO - 10.4196/kjpp.2016.20.1.129

M3 - Article

VL - 20

SP - 129

EP - 136

JO - Korean Journal of Physiology and Pharmacology

JF - Korean Journal of Physiology and Pharmacology

SN - 1226-4512

IS - 1

ER -